1. Home
  2. CHSCL vs VCEL Comparison

CHSCL vs VCEL Comparison

Compare CHSCL & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CHS Inc

CHSCL

CHS Inc

N/A

Current Price

$25.28

Market Cap

0.0

Sector

Industrials

ML Signal

N/A

Logo Vericel Corporation

VCEL

Vericel Corporation

N/A

Current Price

$36.33

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CHSCL
VCEL
Founded
N/A
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
N/A
2.0B
IPO Year
N/A
1997

Fundamental Metrics

Financial Performance
Metric
CHSCL
VCEL
Price
$25.28
$36.33
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$60.40
AVG Volume (30 Days)
N/A
611.9K
Earning Date
N/A
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
236.54
EPS
N/A
0.25
Revenue
N/A
$258,716,999.00
Revenue This Year
N/A
$17.86
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$143.95
Revenue Growth
N/A
14.05
52 Week Low
N/A
$29.24
52 Week High
N/A
$63.00

Technical Indicators

Market Signals
Indicator
CHSCL
VCEL
Relative Strength Index (RSI) 33.99 45.75
Support Level $25.21 $34.79
Resistance Level $25.80 $37.11
Average True Range (ATR) 0.10 1.40
MACD -0.03 -0.33
Stochastic Oscillator 17.29 29.60

Price Performance

Historical Comparison
CHSCL
VCEL

About CHSCL CHS Inc

CHS Inc is an integrated agricultural enterprise, that provides grain, food, and energy resources to businesses and consumers. Its Energy segment produces and provides wholesale distribution of petroleum products and transportation of those products. Its Ag segment, which is the key revenue driver, purchases and processes or resells grains and oilseeds; serves as a wholesaler and retailer of crop inputs; produces and markets ethanol. Its Nitrogen Production segment consists of equity method investment in CF Nitrogen, which entitles the purchase of up to a specified quantity of granular urea and UAN annually from CF Nitrogen. Geographically, the company derives maximum revenue from North America and the rest from South America, Asia Pacific, Europe, Middle East, and Africa (EMEA).

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: